Skip to main content
. 2016 Aug 24;36(6):529–535. doi: 10.3343/alm.2016.36.6.529

Table 3. Clinical characteristics of patients with KPC-2-producing K. pneumoniae and OXA-232-producing K. pneumoniae isolates.

Characteristic N (%) of patients P values
Total (n = 69) KPC-2 (n = 24) OXA-232 (n = 45)
Age (mean ± SD) 64.6 ± 11.8 66.9 ± 8.6 63.4 ± 13.1 0.189
Male gender 53 (76.8) 19 (79.2) 34 (75.6) 0.969
Specimen 0.059
 Respiratory 31 (44.9) 6 (25.0) 25 (55.6)
 Urine 17 (24.6) 8 (33.4) 9 (20.0)
 Wound or pus 9 (13.1) 6 (25.0) 3 (6.7)
 Blood 5 (7.3) 2 (8.3) 3 (6.7)
 Others 7 (10.1) 2* (8.3) 5 (11.0)
ICU hospitalization 34 (49.3) 11 (45.8) 23 (51.1) 0.869
Hospitalization days [median (range)]
 Before CPE isolation 17 (1–187) 40 (2–142) 16 (1–187) 0.006
 After CPE isolation 21 (1–132) 30 (3–124) 12 (1–132) 0.142
Died during hospitalization 19 (27.5) 5 (20.8) 14 (31.1) 0.486

*These two isolates were recovered from bile juice; These five isolates were recovered from catheter tips (n=3), ascites (n=1), and bile juice (n=1).

Abbreviations: KPC, Klebsiella pneumoniae carbapenemase; OXA, oxacillinase; ICU, intensive care unit; CPE, carbapenemase-producing Enterobacteriaceae.